To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
General Information
DRAVP ID DRAVPe00566
Peptide Name P21L9
Sequence LDLTYEMLSLQQVVXALNXSY
Sequence Length 21
UniProt ID No entry found
Source Synthetic construct
Activity Information
Target Organism MERS-CoV
Assay Inhibition of MERS-CoV S-Protein-Mediated Cell–Cell Fusion Assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target membrane
Mechanism The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell–cell fusion.
Structure Information
PDB ID None
Predicted Structure Download No predicted structure available
Linear/Cyclic Linear
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification The 'X' at position 15 and 19 are S5((S)-pentenyl alanine)
Stereochemistry L
Physicochemical Information
Formula C99H154N22O30S
Absent amino acids CFGHIKPRW
Common amino acids L
Mass 2423.19
Pl 3.67
Basic residues 0
Acidic residues 2
Hydrophobic residues 8
Net charge -2
Boman Index -606
Hydrophobicity 41.43
Aliphatic Index 125.24
Half Life
Extinction Coefficient cystines 2980
Absorbance 280nm 149
Polar residues 6
Literature Information
Literature 1
Title Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.
Pubmed ID 29442512
Reference J Med Chem. 2018 Mar 8;61(5):2018-2026.
Author Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.